Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple
Dabigatran versus warfarin in patients with atrial fibrillation
WTA 1000 Indian Wells: Il Tabellone Principale. Camila Giorgi già al secondo turno. Al via anche Trevisan e Paolini (con il md aggiornato)
Marco Antonio Barrera
Dabigatran versus warfarin in patients with atrial fibrillation
Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes.
These findings suggest a role for the addition of pembrolizumab to standard chemotherapy for the first-line treatment of metastatic triple-negative breast cancer.
We aimed to examine whether the addition of pembrolizumab would enhance the antitumour activity of chemotherapy in patients with metastatic triple-negative breast cancer.